0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç×¾ÏÈ­Çпä¹ýÀ» ¹ÞÀº À¯¹æ¾ÏȯÀÚÀÇ ¹«¿ù°æ ¹ß»ý°ú °»³â±â Áõ»ó °ü·Ã¿äÀÎ

Factors of Occurrence of Amenorrhea and Climacteric Symptoms in Breast Cancer Patients Underwent Chemotherapy

¿©¼º°Ç°­°£È£ÇÐȸÁö 2008³â 14±Ç 3È£ p.189 ~ 195
KMID : 0606420080140030189
Àå¼øº¹ ( Chang Soon-Bok ) - ¿¬¼¼´ëÇб³ °£È£´ëÇÐ

ÀÌ°æÈñ ( Lee Kyung-Hi ) - ¼¼ºê¶õ½ºº´¿ø À¯¹æ¼¾ÅÍ ÄÚµð³×ÀÌÅÍ
Á¤Àç¿ø ( Chung Chae-Weon ) - ¼­¿ï´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose:This study aimed to investigate the factors of occurrence of amenorrhea and the severity of climacteric symptoms in breast cancer patients who underwent chemotherapy.

Method:Women diagnosed with breast cancer without metastasis or recurrence, had surgery followed by chemotherapy, and hadmenses at the time of surgery were recruited from S hospital located in Seoul. A total of 99 women aged 31 thru 55 years participated and filled out a structured questionnaire including the Functional Assessment Cancer Therapy-Breast plus Endocrine Symptom when they visited the clinic for follow-up.

Result:In 88 women amenorrhea occurred within an average of 2 months since beginning chemotherapy, and menstruation was resumed in only 11 women. About 98% of women aged over 40 experienced a cessation in menses thus age was an apparent factor of amenorrhea (Exp(B)=.76, p<.05). Presence of chronic disease (©¬=.25, p<.05) and body weight change (©¬=.30, p<.01) were significant factors influencing the severity of climacteric symptoms.

Conclusion:Nurses need to have clinical evidences of menstrual changes due to breast cancer treatment. Information about premature menopause and climacteric symptoms should be provided according to women¡¯s health conditions so that they cope better during their survival.
KeyWords

Breast cancer, Chemotherapy, Amenorrhea, Climacteric
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed